Infusion System Market Size & Share - Growth Forecast Report (2026-2035)

Infusion System Market Overview

The Infusion System Market which was valued at approximately USD 12.9 billion in 2025 and is estimated to reach around USD 14.5 billion in 2026, is projected to reach close to USD 31.4 billion by 2035, expanding at a CAGR of about 9.0% during the forecast period from 2026 to 2035.

The main reason for an increase in demand of infusion pump systems, and therefore the overall infusion system market, is the growing global prevalence of chronic disease such as cancer, diabetes and cardiovascular disease. Due to this, there will be more people in hospital undergoing surgical procedures, resulting in an increase in demand for infusion pump systems. There has been an increase in the ability to accurately treat patients while ensuring their safety through technology innovation such as smart infusion pumps, dose error mitigation systems and wireless connectivity, and this type of technology should be utilised more often in healthcare organisations.

An additional factor leading to a long-term requirement for infusion therapies is the ageing population of the world. This demographic is at a higher risk of developing chronic disease, and therefore will have an ongoing requirement for infusion therapy. Furthermore, the rapid increase in demand for infusion pump systems and other products within the infusion system market can be attributed to the trends toward home health care and ambulatory care services. This is because portable and user-friendly infusion systems allow treatments to take place outside of the hospital setting. Additionally, improvements in government programmes, investment into healthcare infrastructure, and the general availability of high-quality medical equipment in developing economies is improving access to the same. Finally, there is an increased emphasis placed upon patient safety and medication administration on behalf of healthcare professionals. As a result, they are utilising new infusion technologies.

Infusion System Market Dynamics

Market Trends

Home healthcare and ambulatory infusion are two trends which have made it possible for people to receive their treatment at home instead of staying in hospitals. Home-based treatments are less expensive and allow people to continue their normal routines. Because these devices are portable, safe, easy-to-use and can provide medication in many different locations outside of a hospital, they help support the shift from hospital to home-based therapies. To improve local production in the medical device industry, the Indian government has established a USD 400+ million PLI scheme specifically for the medical devices sector and will be providing financial incentives to producers of critical medical devices such as infusion pumps and associated systems. Healthcare providers are trying to promote outpatient care models so that there is an increase in efficiency and a reduction in pressure placed on hospitals. As well as being able to reduce the number of visits by patients to hospitals, clinicians are now able to monitor the progress of patients through the use of new remote monitoring technologies and compact pump designs. The trend toward home-based care is growing rapidly because of the increased awareness of infections related to hospital stays. Insurance providers and healthcare systems are also encouraged to do so because of the economic benefits of ambulatory infusion services..

Growth Drivers

The growing number of chronic disease cases has become a major factor for the increased utilisation of the infusion system across many countries' health systems. Many of the chronic disease cases, including diabetes, cancer, cardiovascular disease and autoimmune diseases, require long-term treatment using infusion equipment. These long-term treatments typically involve finely controlling the amount of medication administered over time, and thus infusion pumps are an important piece of medical equipment to provide effective patient treatment. Chronic illness cases are placing long-term pressures on hospitals, clinics and home care service providers to develop effective drug delivery systems. Due to lifestyle changes and increasing urban populations, there is no indication that the rate of increase of chronic disease cases will slow down globally. As a result, many people are having to rely on portable infusion devices at their homes instead of making repeated trips to the hospital for their ongoing treatment needs. Healthcare providers are increasingly relying on infusion technology to effectively manage complex treatment protocols. It appears that the trend toward more chronic disease cases will continue and, as such, the demand for infusion systems will continue to grow in coming years.

Market Restraints / Challenges

The high expense of advanced infusion systems continues to represent an obstacle for this technology to develop further in terms of market potential. The cost of implementing smart infusion pump systems that utilise contemporary technology, including smart features, communication capabilities and safety features, is typically very high and represents a financial burden to hospitals. This is one reason why smaller healthcare organisations and private practices do not purchase or implement smart infusion pump systems because they simply cannot afford them. In addition to being expensive to purchase, the ongoing expenses associated with maintenance, upgrading software and training employees should not be overlooked. Advanced infusion technologies are frequently unable to be implemented in developing countries due to budgetary constraints, resulting in lower-quality patient treatments. Additionally, using advanced medical devices such as infusion pump systems to treat patients in private healthcare settings may increase the total cost of treatment. Because of limited budgets, government-funded healthcare facilities will delay replacing older infusion systems with newer versions; this delay will result in decreased efficiency and safety. Manufacturers of infusion pump systems are experiencing an increasing demand to find a way to provide innovative products while keeping prices affordable so as to expand their customer base.

Market Opportunities

Emerging markets present an incredible opportunity for companies operating in the global infusion system market as there is a growing demand for healthcare services. With the development of infrastructure in many countries, including China, and increased access to healthcare services, there is a large potential for increased demand for infusion systems. In addition to this, several countries in Asia Pacific, such as India, Latin America and the Middle East are building new hospitals and clinics. Moreover, governments in these countries are spending billions of dollars on modernising their healthcare infrastructures through the construction of new hospitals and other medical facilities. In addition to this, increases in per capita incomes in many developing economies are allowing an increasing number of people to pay for expensive treatments that require the use of infusion systems. There has been an increase in the number of cases of chronic and infectious diseases in recent years in various parts of the world, including Asia Pacific, Latin America and the Middle East. As a result, it is becoming increasingly important for these countries to develop reliable methods for delivering drugs. Government policies are supporting the modernisation of healthcare through new regulations and additional funding for medical equipment, creating strong growth opportunities for infusion system manufacturers.

Global Infusion System Market Report Coverage

Infusion System Market Segmentation

By Product Type

Large Volume Infusion Systems (Volumetric Pumps) are the largest segment with a market share of about 30% in 2025, as they have been widely used in hospitals to provide continuous and large volume fluid delivery for many different treatments such as hydration, antibiotics and other critical care treatments. Because volumetric pumps can be used continuously to provide a very steady flow rate, they are often seen as an important device within the in-patient setting. They continue to maintain this strong position due to their ability to provide a consistent infusion rate throughout long treatment periods.

Ambulatory Infusion Pumps is the fastest growing segment with a CAGR of 9.3% during the forecast period, as hospitals continue to adopt "home care" and "outpatient care" treatment models; patients are able to be treated for their therapy such as chemo, pain control and insulin delivery outside of a hospital setting through the use of an ambulatory device which will increase patient satisfaction and reduce healthcare costs.

By Technology

Traditional Infusion Systems are the largest segment with a market share of about 60% in 2025, this can be attributed to the fact that these systems have been used for many years and are widely used throughout various types of healthcare institutions worldwide. In addition, the reliance on traditional infusion systems in low-cost environments has increased their utilisation in hospitals. Also, this type of system provides a lower-cost alternative compared to newer advanced infusion technologies. Additionally, healthcare providers continue to prefer these systems because of their familiarity with them. The continued growth of developing countries also contributes to the demand for these traditional infusion systems.

Smart / Specialty Infusion Systems are the fastest growing segment with a CAGR of 9.5% during the forecast period, as the need for advanced safety features (i.e., dose error reduction systems) and real-time infusion data tracking, along with interfacing with hospital information systems, continues to grow. These systems offer many improvements over traditional IV pumps regarding both patient safety and operational efficiency, which will encourage hospitals to invest in these products. In addition, the increased focus on minimising medication errors via the use of digital technology and regulation will also foster their development.

By Mode of Administration

Intravenous (IV) Infusion is the largest segment with a market share of about 55% in 2025, due to the fact that this method of administering fluids, medications or nutrients directly into the bloodstream provides an instantaneous therapeutic effect. This method of treatment is also widely utilised in hospital settings and emergency situations, as well as in many other healthcare applications due to its reliability and efficiency. As a result, IV infusion will continue to be one of the most commonly used methods of treatment.

Subcutaneous Infusion is the fastest growing segment with a CAGR of 9.6% during the forecast period, due to increasing use in long-term treatments for various chronic conditions (e.g. biologics; insulin) which provide ease and comfort for patients when used at home. Its accelerated growth is backed by the increasing popularity of minimally invasive and self-administered procedures.

By Application

Oncology / Chemotherapy is the largest segment with a market share of about 25% in 2025, the growing incidence of cancer worldwide has led to an increased need for continuous delivery of chemotherapeutic agents; however, accurate and constant delivery of these agents can be difficult without proper use of infusion systems. The increasing population of treatment centres and targeted therapies have kept the demand in this segment growing.

Diabetes Management is the fastest growing segment during the forecast period, because of the increasing number of people diagnosed with diabetes and an increase in the number of patients using insulin infusion pumps as part of their long-term continuous blood sugar level management. Continuous delivery of insulin through these pumps provides an improved outcome for patients by providing a controlled and precise delivery of insulin. The growing awareness levels and use of wearable insulin pumps, along with the growing use of the devices, make the segment grow rapidly.

By Usage

Stationary Infusion Systems are the largest segment with a market share of about 65% in 2025, due to the fact that these systems provide the ability for continuous or periodic monitoring; therefore, they can be used in hospitals, intensive care units and/or in surgical areas where high volume infusion may be necessary. Because of its reliability and capabilities of administering multiple treatments over long periods of time, this type of infusion system has become preferred in many medical facilities. Their leading role is due to their established presence in the healthcare infrastructure.

Ambulatory / Portable Infusion Systems are the fastest growing segment during the forecast period, due to increasing demand for outpatient care and home-based interventions. The convenience and flexibility provided by these types of systems allows the patient to complete therapy while at home. The growth is triggered by the rising pressure on healthcare costs and higher mobility of patients.

By End User

Hospitals are the largest segment with a market share of about 55% in 2025, due to their high volume of patient populations for in-patient treatments, surgeries and critical care patients who require IV (intravenous) infusions. These institutions have both the physical resources and skilled professionals needed to provide complex infusion therapy services. They are the key players in the provision of healthcare, and this makes the infusion systems demand to be sustained.

Home Healthcare Settings are the fastest growing segment during the forecast period, as there will be an increasing amount of long-term disease management and decentralised care at home. Hospital visits by patients will occur less frequently while they enjoy a better level of comfort, and as a result, the burden on the health system for operations is decreased. The development of portable infusion devices and remote monitoring technologies also contribute to this trend.

Regional Insights

North America

North America is the largest regional market for infusion systems, primarily due to a very high level of healthcare expenditure, as well as the presence of highly developed and technologically sophisticated healthcare delivery infrastructure. Additionally, there is a high rate of adoption of innovative infusion technology within this region. As such, the United States holds the leading position in terms of volume in the North American region. This status is likely to be maintained due to the large number of hospitals located throughout the U.S., coupled with the widespread prevalence of chronic disease and early adoption of smart infusion pumps. A second factor contributing to growth in the U.S. infusion pump market is the presence of several large-scale medical device manufacturers that drive product innovation. Regulatory support, including reimbursement policies and funding from agencies such as AHRQ, also encourages adoption of safe and effective infusion technologies. Another key driver is the increasing ageing population requiring long-term care. Adoption of connected infusion devices continues to grow due to integrated digital healthcare systems, while expansion of home healthcare and outpatient services further supports demand. Overall, North America is expected to maintain its leadership due to its well-established, technology-based healthcare ecosystem.

Asia-Pacific

Asia-Pacific is the fastest-growing regional market for infusion systems. This growth can be attributed to the rapid development of healthcare infrastructure and an increasing number of patients. As a result of high investment by the Chinese and Indian governments into healthcare, as well as the increasing number of diseases they are experiencing, these countries, along with Japan, have been at the forefront of this growth. The growth of hospitals and better access to healthcare services throughout the region has created a greater need for infusion systems. In order to improve healthcare infrastructure, several government policies, including funding, are being implemented. Recently, the Government of China has greatly increased its expenditure on public healthcare. According to recent figures, China's total expenditure on public healthcare was over CNY 2 trillion annually in recent years, with a significant portion allocated to building new hospitals, expanding ICUs and purchasing advanced medical technology. Additional growth in the Asia-Pacific region is also due to an increase in private healthcare providers and medical travel. An increased focus on patient safety and accurate treatments is leading to the adoption of newer infusion technologies, along with a shift towards home care and portable infusion equipment.

Europe

Europe holds a significant share in the infusion system market, supported by well-established healthcare systems and high standards of patient care. Germany, France, and United Kingdom are among countries that contribute significantly to the demand. The area focuses on patient safety and compliance with regulations, which facilitate the integration of innovative infusion technologies. The sustained demand is supported by increasing prevalence of chronic diseases and an ageing population. Effective clinical healthcare systems guarantee wide access to infusion therapies. the European Commission approved up to €403 million in public funding to support innovation in medical devices, including infusion-related technologies. This initiative focuses on integrating digital and AI capabilities into medical devices and is expected to unlock an additional €800+ million in private investment. The program strengthens Europe’s medical technology ecosystem and supports the development of next-generation infusion systems. Digital health and connected medical devices investments are enhancing efficiency of treatment. The increases in home care and ambulatory services also add to the growth of the market. Europe is also showing steady growth with quality healthcare provision.

Rest of the World

The Rest of the World (Middle East, Latin America and Africa) has steady and emerging growth in the infusion system industry, mainly due to advancements in access to and infrastructure of the healthcare system. As an example, Latin American countries, including Brazil and Mexico, are adding new hospital facilities and implementing the use of medical technology. Countries in the Middle East are also rapidly modernising their healthcare systems, especially the United Arab Emirates and Saudi Arabia. Healthcare systems are gradually developing throughout Africa; however, there are many barriers to both access and affordability. Demand for infusion therapy is increasing as the number of people living with chronic disease rises and as awareness of advanced treatments continues to grow. Government support, along with medical tourism, are also factors that contribute to increased demand for infusion therapy. Although the gap in infrastructure may not be fully narrowed, with continued investments, the adoption of infusion systems is likely to improve with time.

Competitive Landscape / Company Insights

Infusion system manufacturers include a wide array of both domestic and international competitors across multiple product lines, technology platforms and end-user segments. This results from the vast range of infusion device types (volumetric pumps; syringe pumps; insulin pumps; ambulatory systems) as well as the need for specific medical training for safe operation and proper design. While many large infusion equipment producers (e.g. Becton Dickinson & Co.; Baxter International Inc.; B. Braun Melsungen AG) dominate certain areas of the market, the presence of numerous mid-sized and smaller manufacturers, particularly in emerging markets, adds complexity. Due to many players offering similar products at varying prices, market concentration remains limited. Regulatory requirements, price sensitivities and healthcare infrastructure create opportunities for regional providers to meet specific clinical needs.

Manufacturers are developing smart infusion technologies, wearable and portable devices, and connected digital health systems to compete. Companies continue to enhance patient safety through dose error reduction, connectivity and user-friendly interfaces in clinical and homecare settings. Strategic initiatives include partnerships, acquisitions and product launches, along with expansion into emerging markets. Innovation, regulatory compliance and cost-effective solutions define the competitive environment.

Mini Profiles

Becton, Dickinson and Company is an international developer and producer of medical technology, including various types of infusion systems, such as smart pumps and medication management systems applied in hospitals and clinical practices.

Baxter International Inc. is a medical organization dealing with infusion pumps, IV solutions, and integrated delivery systems that aid in critical care, nutrition, and medication delivery.

B. Braun Melsungen AG is a medical devices company offering advanced infusion therapy systems, including volumetric and syringe pumps, along with comprehensive hospital solutions.

Fresenius SE & Co. KGaA is a multinational health care company that provides infusion therapy products, clinical nutrition, and medical devices via the several operating divisions.

ICU Medical, Inc. is a medical technology firm that deals with infusion therapy, IV systems and critical care products that aim at improving patient safety and efficiency of treatment.

Medtronic plc is a pioneering medical equipment company that provides insulin pumps and innovative infusion methods that are aimed at the management of diabetes and patient-centered care.

Key Players

• Becton, Dickinson and Company
• Baxter International Inc.
• B. Braun Melsungen AG
• Fresenius SE & Co. KGaA
• ICU Medical, Inc.
• Medtronic plc
• Smiths Group plc
• Terumo Corporation
• Nipro Corporation
• Moog Inc.
• Micrel Medical Devices S.A.
• Insulet Corporation

Recent Developments

March 2026 – Becton, Dickinson and Company announced enhancements to its smart infusion pump platform, focusing on improved interoperability with hospital information systems and advanced dose error reduction features to strengthen patient safety.

February 2026 – ICU Medical, Inc. has enhanced its infusion therapy offering with new product releases to enhance the safety of IVs and workflow in acute care facilities.

November 2025 – Medtronic plc reported developments on its insulin pump technologies with the emphasis to be on the automated insulin delivery system to enhance diabetes managing results.

October 2025 – B. Braun Melsungen AG announced an upgrade to its infusion pump systems with improved safety software and user interface to minimize medication errors.

Table of Contents for Infusion System Market Report

1.    Research Overview

        1.1.    The Report Offers
        1.2.    Market Coverage
                  1.2.1.    By Product Type 
                  1.2.2.    By Technology 
                  1.2.3.    By Mode of Administration 
                  1.2.4.    By Application 
                  1.2.5.    By Usage 
                  1.2.6.    By End User 
        1.3.    Research Phases
        1.4.    Limitations
        1.5.    Market Methodology
                  1.5.1.  Data Sources
                             1.5.1.1. Primary Research
                             1.5.1.2. Secondary Research
                  1.5.2.  Methodology
                             1.5.2.1. Data Exploration
                             1.5.2.2. Forecast Parameters
                             1.5.2.3. Data Validation
                             1.5.2.4. Assumptions
                  1.5.3.  Study Period & Data Reporting Unit

2.    Executive Summary

3.    Industry Overview

       3.1.    Industry Dynamics
                 3.1.1.    Market Growth Drivers
                 3.1.2.    Market Restraints
                 3.1.3.    Key Market Trends
                 3.1.4.    Major Opportunities
       3.2.    Industry Ecosystem
                 3.2.1.    Porter’s Five Forces Analysis
                 3.2.2.    Recent Development Analysis
                 3.2.3.    Value Chain Analysis
       3.3.    Competitive Insight
                 3.3.1.    Competitive Position of Industry Players
                 3.3.2.    Market Attractive Analysis
                 3.3.3.    Market Share Analysis

4.    Global Market Estimate and Forecast

       4.1.    Global Market Overview
       4.2.    Global Market Estimate and Forecast to 2035

5.    Market Segmentation Estimate and Forecast

       5.1.    By Product Type 
                 5.1.1. Large Volume Infusion Systems (Volumetric Pumps)
                           5.1.1.1. Market Definition
                           5.1.1.2. Market Estimation and Forecast to 2035
                 5.1.2. Syringe Infusion Systems
                           5.1.2.1. Market Definition
                           5.1.2.2. Market Estimation and Forecast to 2035
                 5.1.3. Insulin Infusion Systems
                           5.1.3.1. Market Definition
                           5.1.3.2. Market Estimation and Forecast to 2035
                 5.1.4. Elastomeric Infusion Pumps
                           5.1.4.1. Market Definition
                           5.1.4.2. Market Estimation and Forecast to 2035
                 5.1.5. Enteral Feeding Pumps
                           5.1.5.1. Market Definition
                           5.1.5.2. Market Estimation and Forecast to 2035
                 5.1.6. Implantable Infusion Pumps
                           5.1.6.1. Market Definition
                           5.1.6.2. Market Estimation and Forecast to 2035
                 5.1.7. Ambulatory Infusion Pumps
                           5.1.7.1. Market Definition
                           5.1.7.2. Market Estimation and Forecast to 2035
                 5.1.8. Patient-Controlled Analgesia (PCA) Pumps
                           5.1.8.1. Market Definition
                           5.1.8.2. Market Estimation and Forecast to 2035

       5.2.    By Technology 
                 5.2.1. Traditional Infusion Systems
                           5.2.1.1. Market Definition
                           5.2.1.2. Market Estimation and Forecast to 2035
                 5.2.2. Smart / Specialty Infusion Systems
                           5.2.2.1. Market Definition
                           5.2.2.2. Market Estimation and Forecast to 2035

       5.3.    By Mode of Administration 
                 5.3.1. Intravenous (IV) Infusion
                           5.3.1.1. Market Definition
                           5.3.1.2. Market Estimation and Forecast to 2035
                 5.3.2. Subcutaneous Infusion
                           5.3.2.1. Market Definition
                           5.3.2.2. Market Estimation and Forecast to 2035
                 5.3.3. Enteral Infusion
                           5.3.3.1. Market Definition
                           5.3.3.2. Market Estimation and Forecast to 2035
                 5.3.4. Epidural Infusion
                           5.3.4.1. Market Definition
                           5.3.4.2. Market Estimation and Forecast to 2035
                 5.3.5. Others
                           5.3.5.1. Market Definition
                           5.3.5.2. Market Estimation and Forecast to 2035

       5.4.    By Application 
                 5.4.1. Oncology / Chemotherapy
                           5.4.1.1. Market Definition
                           5.4.1.2. Market Estimation and Forecast to 2035
                 5.4.2. Diabetes Management
                           5.4.2.1. Market Definition
                           5.4.2.2. Market Estimation and Forecast to 2035
                 5.4.3. Pain Management (Analgesia)
                           5.4.3.1. Market Definition
                           5.4.3.2. Market Estimation and Forecast to 2035
                 5.4.4. Nutrition (Parenteral & Enteral)
                           5.4.4.1. Market Definition
                           5.4.4.2. Market Estimation and Forecast to 2035
                 5.4.5. Gastroenterology
                           5.4.5.1. Market Definition
                           5.4.5.2. Market Estimation and Forecast to 2035
                 5.4.6. Pediatrics & Neonatology
                           5.4.6.1. Market Definition
                           5.4.6.2. Market Estimation and Forecast to 2035
                 5.4.7. Hematology
                           5.4.7.1. Market Definition
                           5.4.7.2. Market Estimation and Forecast to 2035
                 5.4.8. Others
                           5.4.8.1. Market Definition
                           5.4.8.2. Market Estimation and Forecast to 2035

       5.5.    By Usage 
                 5.5.1. Stationary Infusion Systems
                           5.5.1.1. Market Definition
                           5.5.1.2. Market Estimation and Forecast to 2035
                 5.5.2. Ambulatory / Portable Infusion Systems
                           5.5.2.1. Market Definition
                           5.5.2.2. Market Estimation and Forecast to 2035

       5.6.    By End User 
                 5.6.1. Hospitals
                           5.6.1.1. Market Definition
                           5.6.1.2. Market Estimation and Forecast to 2035
                 5.6.2. Ambulatory Surgical Centers (ASCs)
                           5.6.2.1. Market Definition
                           5.6.2.2. Market Estimation and Forecast to 2035
                 5.6.3. Home Healthcare Settings
                           5.6.3.1. Market Definition
                           5.6.3.2. Market Estimation and Forecast to 2035
                 5.6.4. Clinics
                           5.6.4.1. Market Definition
                           5.6.4.2. Market Estimation and Forecast to 2035
                 5.6.5. Nursing Homes / Long-Term Care Facilities
                           5.6.5.1. Market Definition
                           5.6.5.2. Market Estimation and Forecast to 2035

6.   North America Market Estimate and Forecast

      6.1.    By Product Type   
      6.2.    By Technology   
      6.3.    By Mode of Administration   
      6.4.    By Application   
      6.5.    By Usage   
      6.6.    By End User   
                6.6.1.     U.S. Market Estimate and Forecast
                6.6.2.     Canada Market Estimate and Forecast
                6.6.3.     Mexico Market Estimate and Forecast

7.   Europe Market Estimate and Forecast

      7.1.    By Product Type   
      7.2.    By Technology   
      7.3.    By Mode of Administration   
      7.4.    By Application   
      7.5.    By Usage   
      7.6.    By End User   
                7.6.1.     Germany Market Estimate and Forecast
                7.6.2.     France Market Estimate and Forecast
                7.6.3.     U.K. Market Estimate and Forecast
                7.6.4.     Italy Market Estimate and Forecast
                7.6.5.     Spain Market Estimate and Forecast
                7.6.6.     Russia Market Estimate and Forecast
                7.6.7.     Rest of Europe Market Estimate and Forecast

8.   Asia-Pacific (APAC) Market Estimate and Forecast

      8.1.    By Product Type   
      8.2.    By Technology   
      8.3.    By Mode of Administration   
      8.4.    By Application   
      8.5.    By Usage   
      8.6.    By End User   
                8.6.1.     China Market Estimate and Forecast
                8.6.2.     Japan Market Estimate and Forecast
                8.6.3.     India Market Estimate and Forecast
                8.6.4.     South Korea Market Estimate and Forecast
                8.6.5.     Rest of Asia-Pacific Market Estimate and Forecast

9.   Rest of the World (RoW) Market Estimate and Forecast

      9.1.    By Product Type   
      9.2.    By Technology   
      9.3.    By Mode of Administration   
      9.4.    By Application   
      9.5.    By Usage   
      9.6.    By End User   
                9.6.1.     Brazil Market Estimate and Forecast
                9.6.2.     Saudi Arabia Market Estimate and Forecast
                9.6.3.     South Africa Market Estimate and Forecast
                9.6.4.     U.A.E. Market Estimate and Forecast
                9.6.5.     Other Countries Market Estimate and Forecast

10.  Company Profiles

       10.1.   Becton, Dickinson and Company
                  10.1.1.    Snapshot
                  10.1.2.    Overview
                  10.1.3.    Offerings
                  10.1.4.    Financial Insight
                  10.1.5.    Recent Developments
       10.2.   Baxter International Inc.
                  10.2.1.    Snapshot
                  10.2.2.    Overview
                  10.2.3.    Offerings
                  10.2.4.    Financial Insight
                  10.2.5.    Recent Developments
       10.3.   B. Braun Melsungen AG
                  10.3.1.    Snapshot
                  10.3.2.    Overview
                  10.3.3.    Offerings
                  10.3.4.    Financial Insight
                  10.3.5.    Recent Developments
       10.4.   Fresenius SE & Co. KGaA
                  10.4.1.    Snapshot
                  10.4.2.    Overview
                  10.4.3.    Offerings
                  10.4.4.    Financial Insight
                  10.4.5.    Recent Developments
       10.5.   ICU Medical, Inc.
                  10.5.1.    Snapshot
                  10.5.2.    Overview
                  10.5.3.    Offerings
                  10.5.4.    Financial Insight
                  10.5.5.    Recent Developments
       10.6.   Medtronic plc
                  10.6.1.    Snapshot
                  10.6.2.    Overview
                  10.6.3.    Offerings
                  10.6.4.    Financial Insight
                  10.6.5.    Recent Developments
       10.7.   Smiths Group plc
                  10.7.1.    Snapshot
                  10.7.2.    Overview
                  10.7.3.    Offerings
                  10.7.4.    Financial Insight
                  10.7.5.    Recent Developments
       10.8.   Terumo Corporation
                  10.8.1.    Snapshot
                  10.8.2.    Overview
                  10.8.3.    Offerings
                  10.8.4.    Financial Insight
                  10.8.5.    Recent Developments
       10.9.   Nipro Corporation
                  10.9.1.    Snapshot
                  10.9.2.    Overview
                  10.9.3.    Offerings
                  10.9.4.    Financial Insight
                  10.9.5.    Recent Developments
       10.10.   Moog Inc.
                  10.10.1.    Snapshot
                  10.10.2.    Overview
                  10.10.3.    Offerings
                  10.10.4.    Financial Insight
                  10.10.5.    Recent Developments
       10.11.   Micrel Medical Devices S.A.
                  10.11.1.    Snapshot
                  10.11.2.    Overview
                  10.11.3.    Offerings
                  10.11.4.    Financial Insight
                  10.11.5.    Recent Developments
       10.12.   Insulet Corporation
                  10.12.1.    Snapshot
                  10.12.2.    Overview
                  10.12.3.    Offerings
                  10.12.4.    Financial Insight
                  10.12.5.    Recent Developments

11.    Appendix

         11.1.    Exchange Rates
         11.2.    Abbreviations

Note: Financial insight and recent developments of different companies are subject to the availability of information in the secondary domain.